Premedication with gabapentin for laryngoscopy: a double-blind randomized control trial in hypertensive patients
Background & Objective: Laryngoscopy and intubation (L&I) are strong stimulus for cardiovascular system. Hypertensive patients have a greater incidence of coexisting coronary artery disease and cerebrovascular insufficiency. Several methods have been in practice to prevent or alter the hemod...
Gespeichert in:
Veröffentlicht in: | Anaesthesia, pain & intensive care pain & intensive care, 2021-04, Vol.25 (2) |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 2 |
container_start_page | |
container_title | Anaesthesia, pain & intensive care |
container_volume | 25 |
creator | Riasat, Muhammad Imran Chohan, Haris Tariq Kumar, Arun Sultan, Syed Farjad Javaid, Hanya Siddiqui, Safia Zafar |
description | Background & Objective: Laryngoscopy and intubation (L&I) are strong stimulus for cardiovascular system. Hypertensive patients have a greater incidence of coexisting coronary artery disease and cerebrovascular insufficiency. Several methods have been in practice to prevent or alter the hemodynamic response to L&I. Although the main use of gabapentin has been as an antiepileptic, but its effect on the hemodynamic reflexes is still under evaluation. We compared the effectiveness of a single dose of gabapentin 800 mg on the mean arterial pressure (MAP) in response to L&I in hypertensive patients undergoing day care surgery.
Methodology: This randomized, control trial was conducted in operating rooms, Dr Ruth K M Pfau Civil Hospital Karachi, from May 2017 to November 2017. A total of 150 patients undergoing elective surgery requiring general anesthesia with tracheal intubation were included in this study. Patients were randomly allocated equally into two group; Group G (gabapentin group) and Group P (placebo group). Patients in Group G received gabapentin 800 mg and Group P received placebo, 2 h prior to induction of anesthesia. MAP was measured at baseline (before induction), before intubation (after induction), at time 0 (immediately after intubation), and at 1 min, 3 min, 5 min, and 10 min after intubation. Effectiveness was defined as all the MAP reading to be within 30% of the baseline reading.
Results: There were 72(48%) males and 78(52%) females. Effectiveness was significantly higher in patients of Group G, as compared to placebo group (Group P) [94.7% vs. 65.3%; p = 0.0005].
Conclusion: Gabapentin effectively suppresses the increase in MAP in response to laryngoscopy and tracheal intubation as compared to the placebo.
Abbreviations: L&I: Laryngoscopy and intubation; MAP: Mean arterial pressure; ECG: Electrocardiography; ASA: American Society of Anesthesiologists; BMI: Body mass index; SBP: Systolic blood pressure; DBP: Diastolic blood pressure
Key words: Laryngoscopy; Intubation; Hypertension; Gabapentin; Stress response
Citation: Riasat MI, Chohan HT, Kumar A, Sultan SF, Javaid H, Siddiqui SZ. Premedication with gabapentin for laryngoscopy: a double-blind randomized control trial in hypertensive patients. Anaesth. pain intensive care 2021;25(2):163-169. DOI: 10.35975/apic.v25i2.1464 |
doi_str_mv | 10.35975/apic.v25i2.1464 |
format | Article |
fullrecord | <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_35975_apic_v25i2_1464</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_35975_apic_v25i2_1464</sourcerecordid><originalsourceid>FETCH-LOGICAL-c196t-d357d9eb44780fed1587eeee1e03df12ddb00325685974904b3bbf55044ba86f3</originalsourceid><addsrcrecordid>eNotkEtLAzEcxIMoWGrvHvMFtua5D29SfBQKetDzkmz-aSPbZElipX560-pc5jQzzA-hW0qWXHaNvFOTG5YHJh1bUlGLCzRjjJFKNl13iWa0Jk3Vcsau0SKlT1IkRUulnKHpLcIejBtUdsHjb5d3eKu0msBn57ENEY8qHv02pCFMx3ussAlfeoRKj84bHJU3Ye9-wOAh-BzDiHN0asQlvDtOEDP45A6ApzJQOtMNurJqTLD49zn6eHp8X71Um9fn9ephUw20q3NluGxMB1qIpiUWDJVtA0UUCDeWMmM0IZzJui3_RUeE5lpbKYkQWrW15XNE_nqHGFKKYPspun250lPSn6H1J2j9GVp_gsZ_AXp0ZG0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Premedication with gabapentin for laryngoscopy: a double-blind randomized control trial in hypertensive patients</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Riasat, Muhammad Imran ; Chohan, Haris Tariq ; Kumar, Arun ; Sultan, Syed Farjad ; Javaid, Hanya ; Siddiqui, Safia Zafar</creator><creatorcontrib>Riasat, Muhammad Imran ; Chohan, Haris Tariq ; Kumar, Arun ; Sultan, Syed Farjad ; Javaid, Hanya ; Siddiqui, Safia Zafar</creatorcontrib><description>Background & Objective: Laryngoscopy and intubation (L&I) are strong stimulus for cardiovascular system. Hypertensive patients have a greater incidence of coexisting coronary artery disease and cerebrovascular insufficiency. Several methods have been in practice to prevent or alter the hemodynamic response to L&I. Although the main use of gabapentin has been as an antiepileptic, but its effect on the hemodynamic reflexes is still under evaluation. We compared the effectiveness of a single dose of gabapentin 800 mg on the mean arterial pressure (MAP) in response to L&I in hypertensive patients undergoing day care surgery.
Methodology: This randomized, control trial was conducted in operating rooms, Dr Ruth K M Pfau Civil Hospital Karachi, from May 2017 to November 2017. A total of 150 patients undergoing elective surgery requiring general anesthesia with tracheal intubation were included in this study. Patients were randomly allocated equally into two group; Group G (gabapentin group) and Group P (placebo group). Patients in Group G received gabapentin 800 mg and Group P received placebo, 2 h prior to induction of anesthesia. MAP was measured at baseline (before induction), before intubation (after induction), at time 0 (immediately after intubation), and at 1 min, 3 min, 5 min, and 10 min after intubation. Effectiveness was defined as all the MAP reading to be within 30% of the baseline reading.
Results: There were 72(48%) males and 78(52%) females. Effectiveness was significantly higher in patients of Group G, as compared to placebo group (Group P) [94.7% vs. 65.3%; p = 0.0005].
Conclusion: Gabapentin effectively suppresses the increase in MAP in response to laryngoscopy and tracheal intubation as compared to the placebo.
Abbreviations: L&I: Laryngoscopy and intubation; MAP: Mean arterial pressure; ECG: Electrocardiography; ASA: American Society of Anesthesiologists; BMI: Body mass index; SBP: Systolic blood pressure; DBP: Diastolic blood pressure
Key words: Laryngoscopy; Intubation; Hypertension; Gabapentin; Stress response
Citation: Riasat MI, Chohan HT, Kumar A, Sultan SF, Javaid H, Siddiqui SZ. Premedication with gabapentin for laryngoscopy: a double-blind randomized control trial in hypertensive patients. Anaesth. pain intensive care 2021;25(2):163-169. DOI: 10.35975/apic.v25i2.1464</description><identifier>ISSN: 1607-8322</identifier><identifier>EISSN: 2220-5799</identifier><identifier>DOI: 10.35975/apic.v25i2.1464</identifier><language>eng</language><ispartof>Anaesthesia, pain & intensive care, 2021-04, Vol.25 (2)</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Riasat, Muhammad Imran</creatorcontrib><creatorcontrib>Chohan, Haris Tariq</creatorcontrib><creatorcontrib>Kumar, Arun</creatorcontrib><creatorcontrib>Sultan, Syed Farjad</creatorcontrib><creatorcontrib>Javaid, Hanya</creatorcontrib><creatorcontrib>Siddiqui, Safia Zafar</creatorcontrib><title>Premedication with gabapentin for laryngoscopy: a double-blind randomized control trial in hypertensive patients</title><title>Anaesthesia, pain & intensive care</title><description>Background & Objective: Laryngoscopy and intubation (L&I) are strong stimulus for cardiovascular system. Hypertensive patients have a greater incidence of coexisting coronary artery disease and cerebrovascular insufficiency. Several methods have been in practice to prevent or alter the hemodynamic response to L&I. Although the main use of gabapentin has been as an antiepileptic, but its effect on the hemodynamic reflexes is still under evaluation. We compared the effectiveness of a single dose of gabapentin 800 mg on the mean arterial pressure (MAP) in response to L&I in hypertensive patients undergoing day care surgery.
Methodology: This randomized, control trial was conducted in operating rooms, Dr Ruth K M Pfau Civil Hospital Karachi, from May 2017 to November 2017. A total of 150 patients undergoing elective surgery requiring general anesthesia with tracheal intubation were included in this study. Patients were randomly allocated equally into two group; Group G (gabapentin group) and Group P (placebo group). Patients in Group G received gabapentin 800 mg and Group P received placebo, 2 h prior to induction of anesthesia. MAP was measured at baseline (before induction), before intubation (after induction), at time 0 (immediately after intubation), and at 1 min, 3 min, 5 min, and 10 min after intubation. Effectiveness was defined as all the MAP reading to be within 30% of the baseline reading.
Results: There were 72(48%) males and 78(52%) females. Effectiveness was significantly higher in patients of Group G, as compared to placebo group (Group P) [94.7% vs. 65.3%; p = 0.0005].
Conclusion: Gabapentin effectively suppresses the increase in MAP in response to laryngoscopy and tracheal intubation as compared to the placebo.
Abbreviations: L&I: Laryngoscopy and intubation; MAP: Mean arterial pressure; ECG: Electrocardiography; ASA: American Society of Anesthesiologists; BMI: Body mass index; SBP: Systolic blood pressure; DBP: Diastolic blood pressure
Key words: Laryngoscopy; Intubation; Hypertension; Gabapentin; Stress response
Citation: Riasat MI, Chohan HT, Kumar A, Sultan SF, Javaid H, Siddiqui SZ. Premedication with gabapentin for laryngoscopy: a double-blind randomized control trial in hypertensive patients. Anaesth. pain intensive care 2021;25(2):163-169. DOI: 10.35975/apic.v25i2.1464</description><issn>1607-8322</issn><issn>2220-5799</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNotkEtLAzEcxIMoWGrvHvMFtua5D29SfBQKetDzkmz-aSPbZElipX560-pc5jQzzA-hW0qWXHaNvFOTG5YHJh1bUlGLCzRjjJFKNl13iWa0Jk3Vcsau0SKlT1IkRUulnKHpLcIejBtUdsHjb5d3eKu0msBn57ENEY8qHv02pCFMx3ussAlfeoRKj84bHJU3Ye9-wOAh-BzDiHN0asQlvDtOEDP45A6ApzJQOtMNurJqTLD49zn6eHp8X71Um9fn9ephUw20q3NluGxMB1qIpiUWDJVtA0UUCDeWMmM0IZzJui3_RUeE5lpbKYkQWrW15XNE_nqHGFKKYPspun250lPSn6H1J2j9GVp_gsZ_AXp0ZG0</recordid><startdate>20210421</startdate><enddate>20210421</enddate><creator>Riasat, Muhammad Imran</creator><creator>Chohan, Haris Tariq</creator><creator>Kumar, Arun</creator><creator>Sultan, Syed Farjad</creator><creator>Javaid, Hanya</creator><creator>Siddiqui, Safia Zafar</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20210421</creationdate><title>Premedication with gabapentin for laryngoscopy: a double-blind randomized control trial in hypertensive patients</title><author>Riasat, Muhammad Imran ; Chohan, Haris Tariq ; Kumar, Arun ; Sultan, Syed Farjad ; Javaid, Hanya ; Siddiqui, Safia Zafar</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c196t-d357d9eb44780fed1587eeee1e03df12ddb00325685974904b3bbf55044ba86f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Riasat, Muhammad Imran</creatorcontrib><creatorcontrib>Chohan, Haris Tariq</creatorcontrib><creatorcontrib>Kumar, Arun</creatorcontrib><creatorcontrib>Sultan, Syed Farjad</creatorcontrib><creatorcontrib>Javaid, Hanya</creatorcontrib><creatorcontrib>Siddiqui, Safia Zafar</creatorcontrib><collection>CrossRef</collection><jtitle>Anaesthesia, pain & intensive care</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Riasat, Muhammad Imran</au><au>Chohan, Haris Tariq</au><au>Kumar, Arun</au><au>Sultan, Syed Farjad</au><au>Javaid, Hanya</au><au>Siddiqui, Safia Zafar</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Premedication with gabapentin for laryngoscopy: a double-blind randomized control trial in hypertensive patients</atitle><jtitle>Anaesthesia, pain & intensive care</jtitle><date>2021-04-21</date><risdate>2021</risdate><volume>25</volume><issue>2</issue><issn>1607-8322</issn><eissn>2220-5799</eissn><abstract>Background & Objective: Laryngoscopy and intubation (L&I) are strong stimulus for cardiovascular system. Hypertensive patients have a greater incidence of coexisting coronary artery disease and cerebrovascular insufficiency. Several methods have been in practice to prevent or alter the hemodynamic response to L&I. Although the main use of gabapentin has been as an antiepileptic, but its effect on the hemodynamic reflexes is still under evaluation. We compared the effectiveness of a single dose of gabapentin 800 mg on the mean arterial pressure (MAP) in response to L&I in hypertensive patients undergoing day care surgery.
Methodology: This randomized, control trial was conducted in operating rooms, Dr Ruth K M Pfau Civil Hospital Karachi, from May 2017 to November 2017. A total of 150 patients undergoing elective surgery requiring general anesthesia with tracheal intubation were included in this study. Patients were randomly allocated equally into two group; Group G (gabapentin group) and Group P (placebo group). Patients in Group G received gabapentin 800 mg and Group P received placebo, 2 h prior to induction of anesthesia. MAP was measured at baseline (before induction), before intubation (after induction), at time 0 (immediately after intubation), and at 1 min, 3 min, 5 min, and 10 min after intubation. Effectiveness was defined as all the MAP reading to be within 30% of the baseline reading.
Results: There were 72(48%) males and 78(52%) females. Effectiveness was significantly higher in patients of Group G, as compared to placebo group (Group P) [94.7% vs. 65.3%; p = 0.0005].
Conclusion: Gabapentin effectively suppresses the increase in MAP in response to laryngoscopy and tracheal intubation as compared to the placebo.
Abbreviations: L&I: Laryngoscopy and intubation; MAP: Mean arterial pressure; ECG: Electrocardiography; ASA: American Society of Anesthesiologists; BMI: Body mass index; SBP: Systolic blood pressure; DBP: Diastolic blood pressure
Key words: Laryngoscopy; Intubation; Hypertension; Gabapentin; Stress response
Citation: Riasat MI, Chohan HT, Kumar A, Sultan SF, Javaid H, Siddiqui SZ. Premedication with gabapentin for laryngoscopy: a double-blind randomized control trial in hypertensive patients. Anaesth. pain intensive care 2021;25(2):163-169. DOI: 10.35975/apic.v25i2.1464</abstract><doi>10.35975/apic.v25i2.1464</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1607-8322 |
ispartof | Anaesthesia, pain & intensive care, 2021-04, Vol.25 (2) |
issn | 1607-8322 2220-5799 |
language | eng |
recordid | cdi_crossref_primary_10_35975_apic_v25i2_1464 |
source | Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
title | Premedication with gabapentin for laryngoscopy: a double-blind randomized control trial in hypertensive patients |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T19%3A12%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Premedication%20with%20gabapentin%20for%20laryngoscopy:%20a%20double-blind%20randomized%20control%20trial%20in%20hypertensive%20patients&rft.jtitle=Anaesthesia,%20pain%20&%20intensive%20care&rft.au=Riasat,%20Muhammad%20Imran&rft.date=2021-04-21&rft.volume=25&rft.issue=2&rft.issn=1607-8322&rft.eissn=2220-5799&rft_id=info:doi/10.35975/apic.v25i2.1464&rft_dat=%3Ccrossref%3E10_35975_apic_v25i2_1464%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |